Back to events

Foundation Medicine Live at the 2022 ASCO Annual Meeting

Find Answers. Take Action.

Your Essential Partner in Cancer Care.

Visit us at Booth 13019 at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting to learn more about how we’re delivering comprehensive genomic insights to help providers and researchers find answers and take action on innovative treatment options for patients with cancer.

Our team will be on-site to discuss:

  • How our proven portfolio of tests, including FoundationOne Liquid CDx, the broadest FDA-approved liquid biopsy, can help guide treatment strategies for patients with advanced cancer.
  • Our commitment to simplifying report interpretation, including recent enhancements we’ve made to our test reports to increase visibility to all actionable findings
  • Our integrations with leading EMRs, designed to improve workflow efficiency and help simplify the clinical decision-making process
-

McCormick Place,
2301 S King Dr, Chicago, IL 60616

Schedule a meet & greet

Featured Event and Poster Discussion

Image

Foundation Medicine's ASCO Reception

SUNDAY, JUNE 5 | 7:00 PM - 10:00 PM CDT

We hope you will join us to celebrate the close of another great conference, to speak with the authors of the compelling data we will be presenting, and to learn more from our patient and physician speakers about the impact of Foundation Medicine comprehensive genomic profiling.

Image

Poster Discussion

SUNDAY JUNE 5 | 8:00 AM – 11:00 AM CDT

TITLE: Genomic landscape of acquired resistance to targeted therapies in patients with solid tumors: a study from the National Center for Precision Medicine (PRISM)

ABSTRACT: 3016

TRACK: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Posters & Presentations

Genomic Profile of Intrahepatic Cholangiocarcinoma with MTAP loss

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Abstract/Poster Number

4102/89

Time

8:00 AM-11:00 AM CDT

Location

Hall A

The Landscape of Homologous Recombination Reversion Mutations in Pancreatobiliary Malignancies

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Abstract/Poster Number

4156/141

Time

8:00AM–11:00AM CDT

Location

Hall A

Molecular Characteristics of Advanced Colorectal Cancer and Multi-hit PIK3CA Mutations

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Abstract/Poster Number

3535/329

Time

8:00AM–11:00AM CDT

Location

Hall A

Comprehensive Genomic Profiling (CGP) of Chromophobe Renal Cell Carcinoma (chrRCC) Compared with Non-Chromophobe RCC (nonchrRCC): Impact of FLCN Genomic Alteration (GA) Status

Session Title

Genitourinary Cancer—Kidney and Bladder

Abstract/Poster Number

4550/41

Time

1:15PM–4:15PM CDT

Location

Hall A

Landscape of Fibroblast Growth Factor Receptor (FGFR) Genomic Alterations (GA) in Urothelial Bladder Cancer (UBC)

Session Title

Genitourinary Cancer—Kidney and Bladder

Abstract/Poster Number

4568/59

Time

1:15PM–4:15PM CDT

Location

Hall A

Biomarker Associations of Immune Checkpoint Inhibitor Versus Chemotherapy Effectiveness in First-Line Metastatic Endometrial Carcinomas: A Real-World Study

Session Title

Gynecologic Cancer

Abstract/Poster Number

5596/472

Time

1:15PM–4:15PM CDT

Location

Hall A

The Landscape of Homologous Recombination Reversion Mutations in Gynecologic Malignancies

Session Title

Gynecologic Cancer

Abstract/Poster Number

5576/452

Time

1:15PM–4:15PM CDT

Location

Hall A